by Joe Sauer | Nov 25, 2016 | Federal Circuit Appeal, Standing, Trial Institution
By Joe Sauer In a November 17, 2016 non-precedential decision, a Federal Circuit panel again considered whether its holding in Achates Reference Publishing, Inc. v. Apple Inc., 803 F.3d 652 (Fed. Cir. 2015) remains binding in view of the Supreme Court’s ruling in...
by Jones Day's PTAB Team | Nov 3, 2016 | Pharmaceutical, Trial Institution
By: Irina Britva and Patrick Elsevier On October 17, 2016, the PTAB declined the requests of Swiss Pharma International AG (“Swiss Pharma”) in cases IPR2016-00912, IPR2016-00915, and IPR2016-00916 to institute inter partes reviews (“IPRs”) of three patents owned by...
by Carl Kukkonen | Oct 18, 2016 | Federal Circuit Appeal, Standing, Trial Institution
By Carl Kukkonen Last month, the Federal Circuit in Husky Injection Molding Systems Ltd. v. Athena Automation Ltd., Nos. 2015-1726, 2015-1727 (Fed. Cir. Sep. 23, 2016) addressed the issue of whether assignor estoppel may bar a party from filing a petition for inter...
by Matthew Johnson | Oct 13, 2016 | Final Written Decisions, Petitions, PTAB News, PTAB Trial Basics, Trial Institution
By Matt Johnson (profile) The Patent Trial and Appeal Board has released AIA trial filing and disposition numbers for August 2016. Filings remained near the 150 mark, with 143 total trials being requested in August, 136 of those being requests for Inter Partes Review....
by Jones Day's PTAB Team | Oct 4, 2016 | Trial Institution
The PTAB’s recent institution decision in Intex v. Bestway (IPR2016-00180) is notable for two reasons: (1) it demonstrates that the PTAB does not always conduct a claim-by-claim analysis of every challenged claim in a petition before electing to institute a post-grant...
